FDA-SOL-1118333.doc

FDA-SOL-1118333

Solicitation Number: FDA-SOL-1118333 Subject: Laboratory Equipment Description

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotations are being requested and a written solicitation will not be issued.

Solicitation FDA-SOL-1118333 is being issued as a request for quotation (RFQ). The solicitation and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2005-66. This requirement is being solicited as a Total Small Business Set-aside using Simplified Acquisition Procedures per FAR Subpart 13. A firm-fixed price purchase order is anticipated. The associated North American Industrial Classification System (NAICS) code for this procurement is 334516, with a small business size standard of 500 employees.

The U. S. Food & Drug Administration (FDA), Office of Acquisitions and Grant Services (OAGS) is seeking to purchase a radio frequency (RF) power amplifier and optional maintenance agreement to test medical devices in electromagnetic fields.

All interested companies shall provide a quotation for the following:

Supplies or services and Prices/Costs Line Item

Issue

Price

SALIENT CHARACTERISTICS

The product offered must meet the following salient characteristics:

· Must be a self-contained, air-cooled, broadband, and completely solid-state amplifier

· minimum of 1000 watts rated output power

· 1.0 milliwatt maximum input for rated output

· 700 watts minimum power output @ 1 dB compression

· Minimum of 10 kHz–225 MHz instantaneously frequency response

· ± 3.0 dB maximum and ± 1.0 dB with internal leveling flatness over entire frequency range

· Minimum-50 dBm broadband noise referred to input with no input signal

· 50 ohms, VSWR 1.5:1 maximum input impedance

· 50 ohms nominal output impedance

· Must be able to operate without damage or oscillation for any load impedance (magnitude and phase).

· Must reproduce (within 10%) AM, FM or Pulse modulation.

· Harmonic distortion minus 20 dBc maximum at 750 watts

· primary system power200–260 VAC 50–60 Hz, single phase 5,000 watts maximum

· Remote Control (GPIB/IEEE-488) that allows control of all amplifier functions and monitoring of all status indications.

· Safety Interlock electrical contact closure to disable RF power

Standard Manufacturer’s Warranty

The standard manufacturer’s warranty shall cover protection against defects in materials and workmanship and shall not take effect until inspection and acceptance of the delivered systems and installation. All repairs, if required, shall be performed at the FDA, White Oak, Silver Spring facility.

Maintenance Agreements

The optional maintenance agreements shall cover all items covered in the standard manufacturer’s warranty and shall include parts, labor and travel. The maintenance agreement shall not be exercised until expiration of the standard manufacturer’s warranty. All repairs, if required, shall be performed at the FDA, White Oak, Silver Spring facility.

Option years, if exercised by the Government, are 12-month periods that occurs consecutively following the base year.

DELIVERY

Delivery shall be completed 90 days from receipt of award.

The system should arrive fully assembled, or the quoter should complete minor final assembly of the unit at FDA, White Oak, Silver Spring

F.O.B Destination to:

US Food & Drug Administration

FDA/CDRH/OSEL

Attn: Howard Bassen

10903 New Hampshire Avenue

Building 62, Room 1112

Silver Spring, MD 20993

Provisions & Clauses

The full text of FAR provisions or clauses may be accessed electronically at http://acquisition.gov/comp/far/index.html.

The following solicitation provisions apply to this acquisition:

· FAR 52.212-1, “Instructions to Offerors–Commercial Items” and below addendum applies

All quotes shall be submitted via email to Tomeka.Evans@fda.hhs.gov. Quotes must be firm-fixed-priced. Quotes must include a detailed specification. Quotes must include warranty, maintenance, and delivery terms and conditions. Quotes that do not include all required documents and information may be considered incomplete and may not be considered. The due date and time is Monday, July 8, 2013 at 01:00 PM EST. All questions shall be e-mailed to Tomeka Evans.

· FAR 52.212-2, Evaluation—Commercial Items

The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The following factors shall be used to evaluate offers:

Technical - The Offeror has demonstrated the ability supply laboratory equipment that meets the salient characteristics and warranty and maintenance requirements.

Price - The Offeror ability to submit a complete pricing matrix for a firm fixed-price

· FAR 52.212-3, Offerors Representations and Certifications–Commercial Items

Offerors must complete annual representations and certifications on-line at http://orca.bpn.gov in accordance with FAR 52.212-3, Offerors Representations and Certifications–Commercial Items. If paragraph (j) of the provision is applicable, a written submission is required.

The following contract clauses apply to this acquisition:

· FAR 52.212-4, Contract Terms and Conditions–Commercial Items

· FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders

The following clauses are applicable:

52.204-10, Reporting Executive compensation and First-Tier Subcontract Awards (Aug 2012) (Pub. L. 109-282) (31 U.S.C. 6101 note).

52.209-6, Protecting the Government’ Interest When Subcontracting with Contractors Debarred, Suspended, or Proposed for Debarment (Dec 2010) (31 U.S.C. 6101 note).

52.219-6, Notice of Total Small Business Aside (Nov 2011) (15 U.S.C. 644).

Alternate I (Nov 2011).

52.219-28, Post Award Small Business Program Rerepresentation (Apr 2012) (15 U.S.C. 632(a)(2)).

52.222-3, Convict Labor (June 2003) (E.O. 11755).

52.222-19, Child Labor—Cooperation with Authorities and Remedies (Mar 2012) (E.O. 13126).

52.222-21, Prohibition of Segregated Facilities (Feb 1999).

52.222-26, Equal Opportunity (Mar 2007) (E.O. 11246).

52.222-36, Affirmative Action for Workers with Disabilities (Oct 2010) (29 U.S.C. 793).

52.222-50, Combating Trafficking in Persons (FEB 2009) (22 U.S.C. 7104(g)).

52.223-18, Encouraging Contractor Policies to Ban Text Messaging while Driving (Aug 2011).

52.225-1, Buy American Act--Supplies (Feb 2009) (41 U.S.C. 10a-10d).

52.225-13, Restrictions on Certain Foreign Purchases (Jun 2008) (E.O.’s, proclamations, and statutes administered by the Office of Foreign Assets Control of the Department of the Treasury).

52.232-33, Payment by Electronic Funds Transfer—Central Contractor Registration (Oct. 2003) (31 U.S.C. 3332).

52.233-3, Protest After Award (AUG 1996) (31 U.S.C. 3553).

52.233-4, Applicable Law for Breach of Contract Claim (OCT 2004) (Pub. L. 108-77, 108-78).

(End of Clause)

· FAR 52.217-8 OPTION TO EXTEND SERVICES (NOV 1999)

The Government may require continued performance of any services within the limits and at the rates specified in the contract. These rates may be adjusted only as a result of revisions to prevailing labor rates provided by the Secretary of Labor. The option provision may be exercised more than once, but the total extension of performance hereunder shall not exceed 6 months.

The Contracting Officer may exercise the option by written notice to the Contractor within fifteen (15) days prior to the end of the performance period.

(End of Clause)

· FAR 52.217-9 OPTION TO EXTEND THE TERM OF THE CONTRACT (MAR 2000)

(a) The Government may extend the term of this contract by written notice to the Contractor within ten (10) days prior to the end of the performance period, provided that the Government gives the Contractor a preliminary written notice of its intent to extend at least fifteen (15) days before the contract expires. The preliminary notice does not commit the Government to an extension.

(b) If the Government exercises this option, the extended contract shall be considered to include this option clause.

(c) The total duration of this contract, including the exercise of any options under this clause, shall not exceed five (5) years.

(End of Clause) No DPAS rating applies

PAGE